'Resistant virus' diaporamas de présentation

HIV Treatment Guidelines: Reviewing Essentials for Optimal Care

Sponsored for CME credit by Rush University Medical Center. Supported by an independent educational grant from Gilead Sciences Medical Affairs. HIV Treatment Guidelines: Reviewing Essentials for Optimal Care. Educator. The Very Rev. Father Drew A. Kovach, MD, MDiv. Director of HIV Services

1.28k views • 104 slides

February 12, 2009

February 12, 2009 International Perspectives of Adherence and Resistance to HIV Antiretroviral Therapy David Bangsberg, MD, MPH.

693 views • 60 slides

Case Studies in Prevention Trial Design

610 views • 39 slides

Immunity and pathogen competition

Immunity and pathogen competition. Dominik Wodarz Department of Ecology and Evolution 321 Steinhaus Hall University of California, Irvine CA 92697. Immune system / evolutionary aspects. pathogen competition and evolution on epidemiological level. Immunity and pathogen competition.

400 views • 39 slides

Le resistenze di HIV sono destinate a scomparire?

Le resistenze di HIV sono destinate a scomparire?. Andrea De Luca Istituto di Clinica delle Malattie Infettive Univ . Cattolica S. Cuore, Roma Malattie Infettive Universitarie, AOU, Siena. Background.

472 views • 32 slides

Indications for Initiation of ARV Therapy in Children Age >1 Year

Indications for Initiation of ARV Therapy in Children Age >1 Year. Choice of Initial ARV Therapy. Use ZDV monotherapy only for prophylaxis in indeterminate infant in first 6 weeks of life Use combination ARV therapy with at least 3 drugs Slows disease progression Improves survival

425 views • 28 slides

Adherence to ART

468 views • 26 slides

330 views • 23 slides

PrEP Trials

Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach. Dawn K. Smith, Poloko Kebaabetswe, Kisanga Disasi, Douglas Fleming, Lynn Paxton, and Margarett Davis. PrEP Trials.

306 views • 22 slides

Resistance Testing: What is it? What does it mean?

Resistance Testing: What is it? What does it mean?. How does drug resistance emerge? Overview of methods Advantages and disadvantages Current recommendations for use Jill Taylor, Ph.D. Director Viral Genotyping Laboratory Wadsworth Center New York State Department of Health.

277 views • 18 slides

Michael Roche PhD Student Burnet Institute

HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less efficient mechanism of gp-120 CCR5 engagement that attenuates macrophage tropism. Michael Roche PhD Student Burnet Institute. HIV Resistance to Maraviroc.

191 views • 5 slides